nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—phrenic nerve—lung cancer	0.274	0.644	CbGeAlD
Cinitapride—HTR2A—pulmonary artery—lung cancer	0.0996	0.234	CbGeAlD
Cinitapride—HTR2A—respiratory system—lung cancer	0.0168	0.0393	CbGeAlD
Cinitapride—HTR2A—epithelium—lung cancer	0.014	0.0329	CbGeAlD
Cinitapride—HTR2A—trachea—lung cancer	0.0124	0.0291	CbGeAlD
Cinitapride—HTR2A—lung—lung cancer	0.0089	0.0209	CbGeAlD
Cinitapride—HTR1A—Signaling Pathways—SKI—lung cancer	0.000532	0.000928	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EGF—lung cancer	0.000532	0.000928	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SDC4—lung cancer	0.000521	0.000909	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PTHLH—lung cancer	0.000518	0.000903	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—MAPK3—lung cancer	0.000516	0.000899	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—POMC—lung cancer	0.000513	0.000893	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.000512	0.000892	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—DUSP3—lung cancer	0.000511	0.00089	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—APP—lung cancer	0.000508	0.000886	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—BRAF—lung cancer	0.000506	0.000882	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RHEB—lung cancer	0.000501	0.000873	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6R—lung cancer	0.0005	0.000871	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CREBBP—lung cancer	0.000499	0.00087	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—EGFR—lung cancer	0.000491	0.000855	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.00049	0.000854	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ANXA1—lung cancer	0.000487	0.000849	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MAP2K1—lung cancer	0.000477	0.000831	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GRM8—lung cancer	0.000475	0.000828	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PIK3CD—lung cancer	0.000473	0.000825	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000472	0.000823	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—PIK3CA—lung cancer	0.000469	0.000817	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.000466	0.000812	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—POMC—lung cancer	0.000465	0.00081	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—KRAS—lung cancer	0.000464	0.000808	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL6—lung cancer	0.000463	0.000807	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PXN—lung cancer	0.000462	0.000806	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—APP—lung cancer	0.000462	0.000805	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SKI—lung cancer	0.00046	0.000801	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AVP—lung cancer	0.000458	0.000798	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GRP—lung cancer	0.000453	0.000789	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKR1C1—lung cancer	0.000453	0.000789	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—OXTR—lung cancer	0.000453	0.000789	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—PIK3CA—lung cancer	0.000452	0.000788	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.00044	0.000767	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—PIK3CA—lung cancer	0.000426	0.000742	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MDM2—lung cancer	0.000424	0.000739	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNG11—lung cancer	0.000424	0.000738	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—RAF1—lung cancer	0.000423	0.000737	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ERBB2—lung cancer	0.000418	0.000729	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CXCL8—lung cancer	0.000416	0.000726	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AVP—lung cancer	0.000416	0.000724	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MTOR—lung cancer	0.000413	0.000719	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PIK3CB—lung cancer	0.000413	0.000719	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.000405	0.000705	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFC—lung cancer	0.000403	0.000703	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PXN—lung cancer	0.000399	0.000696	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CXCL8—lung cancer	0.000397	0.000691	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AVP—lung cancer	0.000395	0.000689	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—HRAS—lung cancer	0.000394	0.000687	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—OXTR—lung cancer	0.000391	0.000681	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GRP—lung cancer	0.000391	0.000681	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKR1C1—lung cancer	0.000391	0.000681	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—AKT1—lung cancer	0.000383	0.000668	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADCY1—lung cancer	0.000381	0.000664	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CASP3—lung cancer	0.00038	0.000661	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL2—lung cancer	0.000379	0.00066	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL6—lung cancer	0.000377	0.000657	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000374	0.000652	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SMARCA4—lung cancer	0.000371	0.000647	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PPP2R1B—lung cancer	0.000371	0.000647	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCND1—lung cancer	0.000369	0.000644	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—JUN—lung cancer	0.000369	0.000642	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNG11—lung cancer	0.000366	0.000638	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CXCL8—lung cancer	0.00036	0.000627	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AVP—lung cancer	0.000359	0.000626	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MMP9—lung cancer	0.000359	0.000625	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000358	0.000624	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HSPB1—lung cancer	0.000358	0.000624	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CDKN1A—lung cancer	0.000357	0.000623	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PTEN—lung cancer	0.000357	0.000621	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTHLH—lung cancer	0.000354	0.000617	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFC—lung cancer	0.000349	0.000607	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—AKT1—lung cancer	0.000348	0.000606	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EP300—lung cancer	0.00034	0.000593	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ANXA1—lung cancer	0.000333	0.00058	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SRC—lung cancer	0.000331	0.000576	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADCY1—lung cancer	0.000329	0.000574	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FLT1—lung cancer	0.000323	0.000562	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—VEGFA—lung cancer	0.000322	0.000561	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SMARCA4—lung cancer	0.000321	0.000559	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PPP2R1B—lung cancer	0.000321	0.000559	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CG—lung cancer	0.00032	0.000557	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—STAT3—lung cancer	0.000319	0.000556	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NRAS—lung cancer	0.000318	0.000554	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOTCH3—lung cancer	0.000316	0.00055	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APP—lung cancer	0.000316	0.00055	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF9—lung cancer	0.000313	0.000546	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HSPB1—lung cancer	0.000309	0.000539	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTHLH—lung cancer	0.000306	0.000533	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MAPK3—lung cancer	0.000305	0.000531	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—POMC—lung cancer	0.000304	0.00053	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—JUNB—lung cancer	0.000299	0.000521	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MYC—lung cancer	0.000296	0.000516	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CG—lung cancer	0.00029	0.000506	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EGFR—lung cancer	0.00029	0.000505	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ANXA1—lung cancer	0.000288	0.000501	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CD—lung cancer	0.000281	0.000489	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FLT1—lung cancer	0.000279	0.000486	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—POMC—lung cancer	0.000276	0.000481	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CG—lung cancer	0.000276	0.000481	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—KRAS—lung cancer	0.000274	0.000477	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APP—lung cancer	0.000273	0.000475	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOTCH3—lung cancer	0.000273	0.000475	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STK11—lung cancer	0.000271	0.000473	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF9—lung cancer	0.000271	0.000471	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6R—lung cancer	0.000269	0.00047	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—POMC—lung cancer	0.000263	0.000458	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FOXO3—lung cancer	0.000262	0.000457	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—JUNB—lung cancer	0.000258	0.00045	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MAP2K1—lung cancer	0.000257	0.000447	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CD—lung cancer	0.000255	0.000445	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PIK3CA—lung cancer	0.000252	0.000438	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CG—lung cancer	0.000251	0.000437	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AVP—lung cancer	0.000246	0.000428	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CB—lung cancer	0.000245	0.000427	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TP53—lung cancer	0.000243	0.000424	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CD—lung cancer	0.000243	0.000423	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—POMC—lung cancer	0.000239	0.000416	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1R—lung cancer	0.000236	0.000412	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CXCL8—lung cancer	0.000235	0.00041	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STK11—lung cancer	0.000235	0.000409	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6R—lung cancer	0.000233	0.000406	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HRAS—lung cancer	0.000233	0.000406	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HES1—lung cancer	0.000232	0.000405	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—RAF1—lung cancer	0.000228	0.000397	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FOXO3—lung cancer	0.000226	0.000394	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—IL2—lung cancer	0.000225	0.000392	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6—lung cancer	0.000223	0.000388	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CB—lung cancer	0.000222	0.000387	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MAP2K1—lung cancer	0.000222	0.000387	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CD—lung cancer	0.00022	0.000384	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCL8—lung cancer	0.000214	0.000372	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ERBB3—lung cancer	0.000212	0.00037	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AVP—lung cancer	0.000212	0.00037	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CB—lung cancer	0.000212	0.000369	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKT1—lung cancer	0.000206	0.000358	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL2—lung cancer	0.000204	0.000356	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1R—lung cancer	0.000204	0.000356	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TERT—lung cancer	0.000203	0.000355	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCL8—lung cancer	0.000203	0.000354	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HES1—lung cancer	0.000201	0.00035	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGFR1—lung cancer	0.000198	0.000344	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—RAF1—lung cancer	0.000197	0.000343	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HIF1A—lung cancer	0.000195	0.000339	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—IL2—lung cancer	0.000194	0.000339	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CB—lung cancer	0.000192	0.000335	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOA1—lung cancer	0.000188	0.000327	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KDR—lung cancer	0.000186	0.000324	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCL8—lung cancer	0.000185	0.000322	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ERBB3—lung cancer	0.000183	0.00032	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL2—lung cancer	0.000176	0.000307	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TERT—lung cancer	0.000176	0.000306	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CG—lung cancer	0.000171	0.000299	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KIT—lung cancer	0.000171	0.000299	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APC—lung cancer	0.000171	0.000299	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—NRAS—lung cancer	0.000171	0.000299	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGFR1—lung cancer	0.000171	0.000297	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGF—lung cancer	0.000169	0.000295	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HIF1A—lung cancer	0.000168	0.000293	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MAPK3—lung cancer	0.000164	0.000286	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—POMC—lung cancer	0.000163	0.000284	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOA1—lung cancer	0.000162	0.000283	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—BRAF—lung cancer	0.000161	0.000281	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KDR—lung cancer	0.000161	0.00028	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6R—lung cancer	0.000159	0.000277	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CREBBP—lung cancer	0.000159	0.000277	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EGFR—lung cancer	0.000156	0.000272	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAP2K1—lung cancer	0.000152	0.000264	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CD—lung cancer	0.000151	0.000263	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	0.000149	0.00026	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CG—lung cancer	0.000148	0.000258	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APC—lung cancer	0.000148	0.000258	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KIT—lung cancer	0.000148	0.000258	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—NRAS—lung cancer	0.000148	0.000258	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—KRAS—lung cancer	0.000148	0.000257	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGF—lung cancer	0.000146	0.000255	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MAPK3—lung cancer	0.000142	0.000247	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—POMC—lung cancer	0.000141	0.000246	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—BRAF—lung cancer	0.000139	0.000243	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6R—lung cancer	0.000137	0.00024	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CREBBP—lung cancer	0.000137	0.000239	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	0.000136	0.000236	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MDM2—lung cancer	0.000135	0.000235	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EGFR—lung cancer	0.000135	0.000235	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RAF1—lung cancer	0.000135	0.000234	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ERBB2—lung cancer	0.000133	0.000232	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CB—lung cancer	0.000131	0.000229	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MTOR—lung cancer	0.000131	0.000229	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAP2K1—lung cancer	0.000131	0.000228	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CD—lung cancer	0.00013	0.000227	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	0.000129	0.000225	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—KRAS—lung cancer	0.000127	0.000222	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL8—lung cancer	0.000126	0.00022	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HRAS—lung cancer	0.000125	0.000219	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT1—lung cancer	0.000122	0.000212	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASP3—lung cancer	0.000121	0.000211	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL2—lung cancer	0.000121	0.00021	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6—lung cancer	0.00012	0.000209	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCND1—lung cancer	0.000118	0.000205	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—JUN—lung cancer	0.000117	0.000204	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	0.000117	0.000204	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MDM2—lung cancer	0.000117	0.000203	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RAF1—lung cancer	0.000116	0.000203	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ERBB2—lung cancer	0.000115	0.0002	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP9—lung cancer	0.000114	0.000199	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDKN1A—lung cancer	0.000114	0.000198	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTEN—lung cancer	0.000113	0.000198	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MTOR—lung cancer	0.000113	0.000198	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CB—lung cancer	0.000113	0.000198	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT1—lung cancer	0.000111	0.000193	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL8—lung cancer	0.000109	0.00019	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HRAS—lung cancer	0.000108	0.000189	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EP300—lung cancer	0.000108	0.000189	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT1—lung cancer	0.000105	0.000184	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SRC—lung cancer	0.000105	0.000183	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASP3—lung cancer	0.000104	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL2—lung cancer	0.000104	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6—lung cancer	0.000104	0.000181	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFA—lung cancer	0.000103	0.000179	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCND1—lung cancer	0.000102	0.000177	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STAT3—lung cancer	0.000102	0.000177	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—JUN—lung cancer	0.000101	0.000177	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NRAS—lung cancer	0.000101	0.000176	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP9—lung cancer	9.86e-05	0.000172	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDKN1A—lung cancer	9.83e-05	0.000171	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTEN—lung cancer	9.8e-05	0.000171	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAPK3—lung cancer	9.7e-05	0.000169	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT1—lung cancer	9.57e-05	0.000167	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MYC—lung cancer	9.43e-05	0.000164	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EP300—lung cancer	9.35e-05	0.000163	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGFR—lung cancer	9.23e-05	0.000161	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SRC—lung cancer	9.09e-05	0.000158	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFA—lung cancer	8.86e-05	0.000154	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STAT3—lung cancer	8.77e-05	0.000153	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NRAS—lung cancer	8.75e-05	0.000152	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KRAS—lung cancer	8.71e-05	0.000152	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAPK3—lung cancer	8.38e-05	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MYC—lung cancer	8.15e-05	0.000142	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CA—lung cancer	8.01e-05	0.00014	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGFR—lung cancer	7.97e-05	0.000139	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TP53—lung cancer	7.75e-05	0.000135	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KRAS—lung cancer	7.53e-05	0.000131	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HRAS—lung cancer	7.41e-05	0.000129	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6—lung cancer	7.09e-05	0.000124	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CA—lung cancer	6.92e-05	0.000121	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TP53—lung cancer	6.69e-05	0.000117	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT1—lung cancer	6.54e-05	0.000114	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HRAS—lung cancer	6.4e-05	0.000112	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6—lung cancer	6.12e-05	0.000107	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT1—lung cancer	5.65e-05	9.85e-05	CbGpPWpGaD
